Does LEUPROLIDE Cause Pulmonary embolism? 282 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 282 reports of Pulmonary embolism have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.4% of all adverse event reports for LEUPROLIDE.
282
Reports of Pulmonary embolism with LEUPROLIDE
0.4%
of all LEUPROLIDE reports
48
Deaths
155
Hospitalizations
How Dangerous Is Pulmonary embolism From LEUPROLIDE?
Of the 282 reports, 48 (17.0%) resulted in death, 155 (55.0%) required hospitalization, and 23 (8.2%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which LEUPROLIDE Alternatives Have Lower Pulmonary embolism Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM